The AI in neurology market is gaining momentum as healthcare providers apply artificial intelligence to analyze neurological data, support clinical decisions, and improve the diagnosis of conditions such as Alzheimer's disease, Parkinson's disease, and stroke. Valued at USD 759.2 million in 2025, the market is projected to reach USD 945.6 million in 2026 and USD 5,619.9 million by 2034, growing at a CAGR of 25.0% during the forecast period 2026–2034. Key players include Activ Surgical, Airamed GmbH, Brainomix Limited, BrainQ Technologies Ltd., Canon Inc., GE Healthcare, Koninklijke Philips N.V., Medtronic Plc, Neosoma Inc., Neuralink Corporation, Neurox, NVIDIA Corporation, Qure.AI, Siemens Healthineers AG, and Viz.ai Inc.

Deep Learning Leads Technology Adoption

Deep learning dominated the technology landscape in 2025 with 44.6% of revenue, owing to its strength in processing complex neurological data and delivering high accuracy. These models are widely used for imaging-based analysis, pattern recognition, and disease prediction across neuroimaging and clinical datasets. Polaris rates the adoption level of deep learning as very high, describing it as the core technology for neuroimaging and pattern recognition. Growing access to healthcare data and advances in computing ability are accelerating adoption, while the pharmaceutical industry also applies AI to speed drug development. Competition among healthcare technology firms, AI software vendors, and medical equipment makers is shaped by algorithm precision, clinical validation, hospital integration, and regulatory adherence.

Machine Learning and Predictive Analytics Expand Clinical Utility

Machine learning is expected to grow rapidly at a CAGR of 25.6% during the forecast period, supported by its expanding role in patient monitoring and risk assessment. In neurosurgical settings, machine learning algorithms are used for risk assessment, surgical planning, and outcome prediction. Polaris classifies predictive analytics as a high-adoption technology with fast-growing use in early risk detection, disease progression tracking, and treatment planning. Together these tools help healthcare organizations achieve shorter diagnostic periods, greater imaging precision, and better resource allocation, which Polaris associates with financial gains and lower future treatment expenses. Natural language processing is emerging at medium adoption levels for clinical documentation and patient data analysis.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/ai-in-neurology-market

Neuroimaging AI and Clinical Decision Support in Practice

Diagnostics held a 40.5% share in 2025 because of rising adoption of neuroimaging AI to analyze MRI and CT scans for stroke, Alzheimer's disease, and brain tumors. These tools enable earlier detection and more accurate assessment of neurological disorders. Hospitals accounted for the leading end-user share of 54.6% in 2025, supported by advanced imaging infrastructure. In April 2026, Viz.ai collaborated with the National Rural Health Association to expand AI adoption in rural hospitals, enabling real-time analysis of imaging and clinical data to detect conditions such as stroke and pulmonary embolism. Providers are focused on increasing diagnostic accuracy, lowering time to treatment, and optimizing clinical decision support using sophisticated AI models, while neuroimaging AI remains the most visible application.

Demand Drivers and Regional Outlook for the AI in Neurology Market

Rising prevalence of neurological disorders is the foremost driver. Alzheimer's Disease International reports that more than 55 million people had dementia worldwide in 2020, a figure estimated to reach 78 million by 2030 and 139 million by 2050. Aging populations reinforce the need for early detection and continuous monitoring, while high implementation costs and regulatory complexities limit deployment in smaller healthcare facilities and developing nations. North America dominated with a 40.63% revenue share on strong hospital AI in Neurology, and Asia Pacific is growing at a CAGR of 25.6% on heavy government investment and expanding healthcare infrastructure. In Europe, strict regulatory compliance and a strong focus on AI ethics shape adoption, with patient data privacy and transparency prioritized across countries. The regulatory framework has promoted proper use of AI solutions in neurology, and demand remains steady due to increasing use of AI in diagnostics and decision support systems. As deep learning, machine learning, neuroimaging AI, clinical decision support, and predictive analytics mature, the market is positioned to approach USD 5,619.9 million by 2034.

More Trending Latest Reports By Polaris Market Research:

Gynecological Examination Chairs Market

Fluoropolymers Market

Safari Tourism Market

Enterprise Content Management Market

Automotive Ceramics Market

Mass Flow Controller Market

Hemophilia A Treatment Market

AI Trust, Risk and Security Management Market